FIELD: pharmaceutical technology. SUBSTANCE: liniment has the following components, g: analgin 2.37-2.62; methylsalicylate 2.37-2.62; refined naphthalane oil 2.37-2.62; emulsifier N 1 12.4-13.6; synthetic primary saturated alcohols of C16-C21-fraction or synthetic primary saturated alcohols of C16-C20-fraction 2.85-3.15 and purified water - up to 100. Liniment shows analgetic, anti-inflammatory and antipyretic effects and can be used for treatment of patients with locomotor system diseases, mainly, rheumatic arthritis and peripheral nervous system, for example, radiculitis, neuritis. EFFECT: enhanced curative effect of the liniment. 4 tbl
Title | Year | Author | Number |
---|---|---|---|
CREAM "PIROKSIFEN" POSSESSING ANTIINFLAMMATORY AND ANALGETIC ACTION | 2001 |
|
RU2199307C1 |
SOFT MEDICINAL FORM CONTAINING REFINED NAPHTHALANE OIL AND METHOD OF ITS PREPARING | 1999 |
|
RU2135189C1 |
RECTAL SUPPOSITORY "DICLOVIT" | 1996 |
|
RU2104690C1 |
ANTIVIRAL AGENT "GERPEVIR" FOR TOPICAL USE | 1998 |
|
RU2138265C1 |
METHOD FOR PRODUCTION OF POLYVINYL ALCOHOL AND MAGNESIUM OR CALCIUM CHLORIDES POLYHYDRATED COMPLEXES | 2003 |
|
RU2268712C2 |
COMPOSITION FOR TREATMENT OF SKIN VIRAL DISEASE | 1996 |
|
RU2105545C1 |
AGENT FOR TREATMENT OF ARTICULATION DISEASES | 2004 |
|
RU2259204C1 |
SYMPTOMATIC AGENT FOR PAIN AND FEVER ARRESTING (VARIANTS) | 1997 |
|
RU2127583C1 |
AGENT FOR TREATMENT OF JOINT DISEASE | 2004 |
|
RU2271811C1 |
AGENT FOR TREATMENT OF JOINT DISEASE | 2004 |
|
RU2271812C1 |
Authors
Dates
1999-06-20—Published
1997-03-05—Filed